Everett Rand Sutherland

Insider Reports History

Identity 1 identity field
Location
Lexington, MA
SEC source record 1 source field
Owner filing signature
/s/ Allison Ambrose, Attorney-in-Fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Everett Rand Sutherland

Form 4 holding Chief Executive Officer, Director

Upstream Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
225,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Allakos Inc.

Security class
Stock Option (Right to buy)
Shares / value
154,786
Estimated value
Report date
01 Aug 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Krystal Biotech, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
5,000
Estimated value
Report date
30 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President

Translate Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
14 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Everett Rand Sutherland

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .